FilingIndex
8-KThe WireStrategic

Results of Operations

Filed Apr 26, 2017 · 9y ago · Accession 0001157523-17-001207

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

8-K 1 a51542685.htm CHEMED CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (date of earliest event reported): April 26, 2017 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-8351 31-0791746 (State or other  jurisdiction of  incorporation) (Commission File Number)   (I.R.S. Employer Identification Number) Suite 2600, 255 East 5th Street, Cincinnati, OH 45202 (Address of principal executive offices)     (Zip Code) Registrant’s telephone number, including area code: (513) 762-6690 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below): ⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Page 1 of 2 Item 2.02     Results of Operations and Financial Condition On April 26, 2017, Chemed Corporation issued a press release announcing its financial results for the quarter ended March 31, 2017.  A copy of the release is furnished herewith as Exhibit 99. Item 9.01     Financial Statements and Exhibits d)        Exhibit             (99) Registrant’s press release dated April 26, 2017                                     SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     CHEMED CORPORATION     Dated:   April 26, 2017 By:    /s/   Michael D. Witzeman Michael D. Witzeman Vice President and Controller Page 2 of 2 -->
Filing details
Ticker
CHE
CIK
19584
Form type
8-K
Filing date
Apr 26, 2017
Report date
Apr 26, 2017
Document
a51542685.htm
Size
364 KB